Skip to content

Treatment Decision-making in Patients With Recurrent High-grade Glioma

Recurrent High-grade Glioma: Experiences of Patients and Their Close Relatives During the Treatment Decision-making Process.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04013828
Enrollment
29
Registered
2019-07-10
Start date
2019-05-06
Completion date
2022-04-08
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Life Experiences, Malignant Glioma

Keywords

High-grade glioma, Patient experiences, Decision-making, Patient involvement

Brief summary

This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..

Detailed description

High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experience recurrence of tumour growth. At time of recurrence, the treatment possibilities can include surgery, oncological treatment and/or palliative care. In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs. Little is known about how the patients and their close relatives experience the recurrence and the decision-making process. The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence. Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis. The study is part of a larger PhD-study.

Interventions

None listed

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
Region of Southern Denmark
CollaboratorOTHER
Danish Cancer Society
CollaboratorOTHER
Novo Nordisk A/S
CollaboratorINDUSTRY
Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient is offered surgical treatment (after an assesment done by the multidisciplinary team) * Able to speak and understand danish * Able to participate in an interview * Able to give informed concent for participation

Exclusion criteria

* Patients with severe cognitive impairment which prohibits them from either giving informed concent or participating in interview. * Relatives are excluded if the patient do not give concent for the participation of relatives

Design outcomes

Primary

MeasureTime frameDescription
Involvement preferencesInterviews are performed 2-6 weeks after the decision-makingThe preferences of patients and relatives for being involved in the decision-making.
Experiences of patients and relativesInterviews are performed 2-6 weeks after the decision-makingHow patients and their close relatives experience the decision-making process

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026